Atai Life Sciences Initiates Phase 2a Study of BPL-003 with SSRIs for Treatment-Resistant Depression
The BPL-003 Phase 2a trial, conducted by Beckley Psytech under atai Life Sciences, is progressing with significant developments. Recently, Part... Lire la suite
April 26, 2024